Viewing Study NCT04176393


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-03-06 @ 10:19 AM
Study NCT ID: NCT04176393
Status: COMPLETED
Last Update Posted: 2023-02-13
First Post: 2019-10-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation
Sponsor: CStone Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module